Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9275 USD | +6.46% | +5.84% | -13.32% |
Mar. 21 | Transcript : MiNK Therapeutics, Inc., Q4 2023 Earnings Call, Mar 21, 2024 | |
Mar. 21 | MiNK Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Chart calendar MiNK Therapeutics, Inc.
Upcoming events on MiNK Therapeutics, Inc.
Past events on MiNK Therapeutics, Inc.
2024-04-08 12:00 pm | American Association for Cancer Research Meeting - Abstract Number: 1331 |
2024-03-21 08:30 am | Q4 2023 Earnings Call |
2024-03-21 07:00 am | Q4 2023 Earnings Release |
2023-11-09 08:30 am | Q3 2023 Earnings Call |
2023-11-09 07:00 am | Q3 2023 Earnings Release |
2023-10-31 | Society for Immunotherapy of Cancer Meeting - Abstract Number: 735 |
2023-09-13 02:30 pm | H.C. Wainwright Global Investment Conference - Fireside Chat |
2023-09-12 12:15 pm | Baird Global Healthcare Conference - Fireside Chat |
2023-08-10 07:30 am | Q2 2023 Earnings Release |
2023-08-08 11:30 am | BTIG Virtual Biotechnology Conference |
2023-06-13 10:30 am | Annual General Meeting |
2023-05-20 | American Thoracic Society International Conference - Abstract Number : 10725 |
2023-05-19 12:00 pm | American Society of Gene Cell Therapy Meeting - Abstract No: 1488 |
2023-05-11 08:30 am | Q1 2023 Earnings Call |
2023-05-11 08:00 am | Q1 2023 Earnings Release |
2023-04-20 10:00 am | Investor Meeting - Key Opinion Leader |
2023-04-18 01:30 pm | American Association for Cancer Research Meeting - Abstract Number: CT275 |
2023-03-21 08:30 am | Q4 2022 Earnings Call |
2023-03-21 08:00 am | Q4 2022 Earnings Release |
2023-02-28 09:00 am | H.C. Wainwright Cell Therapy Virtual Conference |
Annual results
Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | 0,00 | -28,4 -32,9 13.84% | -30,9 -31,4 1.48% | -22,9 -23,0 0.14% | -22,0 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | -22,5 -22,3 -0.7% | -19,1 |
Net income Million USD | Released Forecast Spread | -16,2 | 0,00 0,00 - | -28,0 -32,0 12.45% | -22,5 -24,8 9.36% | -19,1 |
EPS USD | Released Forecast Spread | -1,87 | 0,00 0,00 - | -0,83 -0,89 6.74% | -0,65 -0,66 2.01% | -0,52 |
Announcement Date | 14/09/21 | 18/03/22 | 21/03/23 | 21/03/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
EBIT Million USD | Released Forecast Spread | -6,36 -10,9 41.72% | -7,37 -7,37 -0% | -7,70 -7,56 -1.83% | -7,99 -8,23 2.98% | -7,89 -8,35 5.57% | -5,85 -8,17 28.37% | -6,34 -6,59 3.8% | -5,22 -6,48 19.45% | -5,50 -5,37 -2.5% | -5,40 | -5,07 | -5,59 | -5,95 | -6,77 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -5,69 -8,09 29.71% | -6,20 -6,21 0.15% | -5,12 -6,08 15.86% | -5,46 -5,30 -2.92% | -5,07 | -4,27 | -4,75 | -4,98 | -6,73 | |||||
Net income Million USD | Released Forecast Spread | -7,77 -8,91 12.81% | -5,69 -8,19 30.54% | -6,20 -6,55 5.37% | -5,12 -6,67 23.26% | -5,46 -5,30 -2.92% | -5,07 | -4,27 | -4,75 | -4,98 | -6,80 | ||||
EPS USD | Released Forecast Spread | -0,23 -0,21 -9.52% | -0,17 -0,24 29.17% | -0,18 -0,19 6.89% | -0,15 -0,17 13.46% | -0,15 -0,15 0% | -0,15 | -0,12 | -0,13 | -0,13 | -0,14 | ||||
Announcement Date | 18/03/22 | 13/05/22 | 09/08/22 | 03/11/22 | 21/03/23 | 11/05/23 | 10/08/23 | 09/11/23 | 21/03/24 | - | - | - | - | - |
Today 04:05 pm | QIAGEN N.V.: Q1 2024 Earnings Release |
2024-04-29 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
2024-04-30 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
2024-04-30 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
2024-04-30 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
2024-04-30 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
2024-05-01 06:30 am | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
2024-05-01 06:30 am | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
2024-05-01 07:00 am | ALKERMES PLC: Q1 2024 Earnings Release |
2024-05-01 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
Past sector events for MiNK Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- INKT Stock
- Calendar MiNK Therapeutics, Inc.